Alectinib Hydrochloride Patent Expiration
Alectinib Hydrochloride was first introduced by Hoffmann-La Roche Inc
Alectinib Hydrochloride Patents
Given below is the list of patents protecting Alectinib Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Alecensa | US10350214 | Preparation containing tetracyclic compound at high dose | Apr 24, 2035 | Hoffmann-la Roche |
| Alecensa | US11433076 | Preparation containing tetracyclic compound at high dose | Apr 24, 2035 | Hoffmann-la Roche |
| Alecensa | US9126931 | Tetracyclic compound | May 29, 2031 | Hoffmann-la Roche |
| Alecensa | US9365514 | Composition comprising tetracyclic compound | Mar 04, 2032 | Hoffmann-la Roche |
| Alecensa | US9440922 | Tetracyclic compound | Jun 09, 2030 | Hoffmann-la Roche |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳